Heights Capital Management’s Rani Therapeutics RANI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$739K Hold
934,580
– – 0.15% 142
2026
Q2
$711K Buy
+934,580
New +$829K 0.16% 134

Other funds holding RANI

Heights Capital Management's RANI Position: Q3 2026 in Review

Heights Capital Management held its Rani Therapeutics (RANI) position steady in Q3 2026 at 934,580 shares worth $739K. The position accounts for 0.15% of the portfolio, ranked #142.

Heights Capital Management first reported a position in RANI in Q2 2026 and has held it in 2 quarters since. 68 funds tracked by Wall St. Rank hold RANI as of Q3 2026.

  • Heights Capital Management held 934,580 shares of Rani Therapeutics worth $739K as of Q3 2026.
  • Heights Capital Management left its Rani Therapeutics share count unchanged in Q3 2026.
  • Rani Therapeutics made up 0.15% of Heights Capital Management's portfolio in Q3 2026, its #142 holding.
  • Heights Capital Management first reported a position in Rani Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • 68 funds tracked by Wall St. Rank held Rani Therapeutics as of Q3 2026.

Based on Heights Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.